Healthcare and digital health companies face a financial landscape unlike any other industry — reimbursement complexity, regulatory compliance costs, payer mix dynamics, and the pressure to scale while maintaining clinical quality. The companies transforming patient care need financial leadership that understands both the business and the regulatory environment.
At DMW Advisory, we bring Wall Street-caliber financial leadership — powered by AI tools that let us operate at the speed and depth of a full finance team — to fractional CFO healthcare digital health companies doing $5M to $50M in revenue.
Growing companies in this space face a unique set of financial complexities that most bookkeepers aren’t equipped to handle — and that don’t yet justify a $250K+ full-time CFO:
We help healthcare and digital health companies navigate financial complexity while scaling operations:
We’ve helped companies across the fractional CFO healthcare digital health landscape gain financial clarity, optimize cash flow, and scale with confidence. Here are a few examples:
Digital Health · Remote Patient Monitoring · $7M Revenue
The Challenge: A remote patient monitoring company had grown to $7M in revenue but was hemorrhaging cash due to reimbursement delays and a poorly managed revenue cycle. Average days in AR exceeded 75, denial rates were above 20%, and the company had no visibility into payer-level profitability. They were burning through their Series A faster than projected.
Our Approach: We conducted a full revenue cycle assessment, implemented payer-level P&L tracking, and redesigned the billing workflow to reduce denials. We built a cash flow model tied to payer reimbursement timelines and restructured the chart of accounts to give visibility into cost-per-patient by program.
The Results: Cash flow stabilized and unit economics became clear:
Healthcare · Telehealth · $15M Revenue
The Challenge: A telehealth platform operating in 8 states was planning expansion to 25 states but lacked the financial infrastructure to model multi-state economics — provider compensation varied by state, reimbursement rates differed by payer and geography, and compliance costs for new state licensing were unknown. The CFO seat was empty after a departure.
Our Approach: We stepped in as fractional CFO to build a state-level economic model, create a phased expansion financial plan, and establish the financial reporting cadence the board required. We modeled provider compensation structures that scaled across states while maintaining target margins, and built a compliance cost database for each target market.
The Results: The expansion plan was financially grounded and board-approved:
Healthcare · MedTech · Pre-Revenue → $5M
The Challenge: An AI-powered diagnostics company was approaching FDA 510(k) clearance with $3M remaining on their balance sheet. They had no financial model connecting regulatory timeline to cash needs, no reimbursement strategy for post-clearance commercialization, and their burn rate was accelerating due to clinical validation costs.
Our Approach: We built a phase-gated financial model tying each regulatory milestone to cash requirements, created a post-clearance commercialization model with reimbursement scenarios by CPT code, and prepared fundraising materials for a bridge round. We also identified $400K in non-essential spending that could be deferred post-clearance.
The Results: The company achieved clearance without running out of capital:
Healthcare companies need financial leadership that understands reimbursement, compliance, and the unique economics of scaling in a regulated industry. If that’s where you are — let’s talk.
Or contact us at genevieve@dmwadvisory.com
AI Financial Advisor — Typically replies instantly
